Status:

RECRUITING

Stroke Volume Variation Versus Central Venous Pressure Guidance for Reducing Perioperative Blood Loss During Open Liver Resection

Lead Sponsor:

Warangkana Lapisatepun

Collaborating Sponsors:

Chiang Mai University

Conditions:

Liver Tumor; Surgery

Primary Liver Tumor, Metastatic Liver

Eligibility:

All Genders

20-70 years

Phase:

NA

Brief Summary

Liver resection is a major surgery that can be associated with significant intraoperative blood loss and blood transfusion. Among high-volume centers, median intraoperative blood loss ranges between 3...

Detailed Description

Bleeding is the most common and concerning complication in liver resection because it affects overall complications. Nowadays, there are numerous surgical and anesthetic techniques to decrease blood l...

Eligibility Criteria

Inclusion

  • All genders, age 18 to 70 years old
  • American Society of Anesthesiologists (ASA) physical status classification of I-III
  • The patients who scheduled in elective open liver resection and diagnosed Hepatocellular Carcinoma, Cholangiocarcinoma, Liver metastasis, and Benign malignant tumor.

Exclusion

  • Pregnancy
  • Active cardiac conditions (unstable coronary syndromes, decompensated heart failure, significant arrhythmias, severe valvular disease, active coronary artery disease within 6 months prior surgery)
  • History of significant cerebrovascular disease (Patients with clinically significant stroke/CVA within 6 months prior surgery, severe carotid stenosis)
  • Renal dysfunction (GFR \< 60 ml/min/1.73 m²)
  • Abnormal coagulation parameters (INR \>1.5 not on warfarin and/or platelet count \<100,000)
  • Preoperative autologous blood donation
  • Tumor size \> 10 cm.
  • Previous liver resection
  • Withdrawal criteria:
  • Unresectable tumor
  • Persistent intraoperative hypotension that cannot be corrected with vasopressors.
  • Cardiac arrest during operation
  • Low central venous pressure (CVP \< 5 mmHg) or high stroke volume variation (SVV \>13%) cannot be achieved before and during liver parenchymal transection.

Key Trial Info

Start Date :

November 25 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 30 2028

Estimated Enrollment :

74 Patients enrolled

Trial Details

Trial ID

NCT06905015

Start Date

November 25 2024

End Date

June 30 2028

Last Update

April 1 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Anesthesiology, Faculty of Medicine, Chiang Mai University

Chiang Mai, Chiangmai, Thailand, 50200